Findings of the first in-depth analysis of clinical and genomic characteristics of the Clade Ib strain, published in the journal Virology, showed seven of the 10 individuals had a history of travel to the United Arab Emirates (UAE).
India has reported 59 cases of Human Metapneumovirus (HMPV) and two deaths due to co-morbidities between January 6 and 29, according to Union Minister Prataprao Jadhav. The virus primarily affects young children, the elderly, and immunocompromised individuals, leading to respiratory illnesses. The government has taken measures to monitor and control the spread of HMPV cases and create public awareness.
Covaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research - National Institute of Virology.
The test kit has the advantage of testing 90 samples together in a single run of 2.5 hours, so that healthcare professionals can proceed quickly with necessary next steps.
India is currently using two vaccines for COVID-19 -- one developed by Oxford University and AstraZeneca and the other developed by Bharat Biotech in collaboration with the Indian Council of Medical Research-National Institute of Virology. Both the vaccines are being manufactured within the country by domestic firms.
The US Food and Drug Administration had in February approved Johnson & Johnson's COVID-19 vaccine that works with just one dose for emergency use.
The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances